Company Number: 198601320
Company Information
Company Industry: Biotechnology Pharmaceuticals Supplies, Equipment and Devices Biomaterials Implantable Devices Therapeutic Area(s) of Focus Non-Specific Similarly Sized Companies: $189.20 mm Company Ownership: Public Company Location: Worldwide North America Canada Back to top
Therapeutic Area(s) of Focus
Similarly Sized Companies:
$189.20 mm
Company Ownership:
Public
Back to top
Deal Information
Deal Activity since 1991 Pharmaceuticals Mergers & Acquisitions 3 Alliances 21 Financial Offerings 5 Medical Devices Mergers & Acquisitions 7 Alliances 18 Financial Offerings 5 Most Recent Deal Activity ... Date Headline Source May-01-2006 Angiotech buys Quill Medical for $40mm plus earn-outs Deal May-01-2006 Angiotech, Genzyme develop combination cancer treatment Deal May-01-2006 Athersys, Angiotech team up for cardiovascular cell therapies Deal Mar-01-2006 Angiotech receives $250mm with private placement of debt Deal Jan-01-2006 Angiotech Pharmaceuticals buys device company AMI Holdings Deal Nov-01-2005 Angiotech buys Edwards' Lifespan product line Deal Oct-01-2005 CombinatoRx, Angiotech in combination drug discovery alliance Deal Aug-01-2005 NuVasive acquires Pearsalls' Neodisc Deal Jun-01-2005 Histogenics licenses Angiotech's ChondroGEL Deal Jun-01-2005 Angiotech licenses paclitaxel to Broncus Technologies Deal Back to top
Deal Activity since 1991
Pharmaceuticals
Mergers & Acquisitions
3
Alliances
21
Financial Offerings
5
Medical Devices
7
18
Most Recent Deal Activity ...
Financial Information
2005 2004 2003 2002 Company Revenue: $ 189.20 $100.64 $20.34 $4.64 Net Earnings: $ -1.19 $-52.45 $-49.40 $-12.74 All Numbers in Thousands Fiscal Year End: December 31 Back to top
Company Revenue:
$ 189.20
$100.64
$20.34
$4.64
Net Earnings:
$ -1.19
$-52.45
$-49.40
$-12.74
Divisions with Deals
AMI Holdings Inc. Angiotech BioMaterials Corp. NeuColl Inc. Pearsalls Ltd. STS Biopolymers Inc. Back to top
AMI Holdings Inc.
Angiotech BioMaterials Corp.
NeuColl Inc.
Pearsalls Ltd.
STS Biopolymers Inc.
Contact Information
Address: 1618 Station St. Vancouver , Canada V6A 1B6 Phone: (604) 221-7676 Fax: (604) 221-2330 Website: http://www.angiotech.com/ Ticker Symbol: ANPI Senior Executives: WIlliam L. Hunter , MD, Pres. & CEO Thomas Bailey , CFO Rui Avelar , CMO Jeanne M. Bertonis , CBO Back to top
Related Documents
Date Headline Source Jan-01-2005 Elephant Cha-Cha: The J&J/Guidant Deal IN VIVO Feb-01-2005 Convergence: What's Next at the Nexus? Start-Up Mar-01-2005 Boston Scientific Takes Conor to Court over DES IN VIVO Apr-01-2005 Breaking the Surgical Adhesion Barrier Start-Up Apr-01-2005 Angiotech's New Partnering Model for the Convergence Era Start-Up Apr-01-2005 The New Math of Drug-Device Convergence IN VIVO Jun-01-2005 Hemoteq's Fancy New Coat IN VIVO Nov-01-2005 Gauging the Risks of Financing Convergence Start-Ups Start-Up Feb-01-2006 Angiotech acquires Device Company, Takes Control of its Destiny IN VIVO May-01-2006 Deal Statistics Quarterly (5/2006) IN VIVO More... Back to top
Company Information 
Biotechnology
Back
to top